Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs

British Journal of Dermatology

Volumn 170, Issue 3, 2014, Pages 725-729

  Corzo, J L ^a   Zambonino, M A ^a   Munoz C ^a   Mayorga, C ^a   Requena, G ^a   Urda, A ^a   Gallego, C ^a   Blanca, M ^a   Torres, M J ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; CYCLOOXYGENASE 2 INHIBITOR; DEXCHLORPHENIRAMINE; DIPYRONE; ETORICOXIB; IBUPROFEN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PYRIDINE DERIVATIVE; SULFONE; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADOLESCENT; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; DRUG HYPERSENSITIVITY; DRUG PROVOCATION TEST; FEMALE; HUMAN; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROVOCATION TEST; RASH; RETROSPECTIVE STUDY; SCHOOL CHILD; URTICARIA; CHEMICALLY INDUCED; DRUG SUBSTITUTION;

ADOLESCENT; ANGIOEDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; CHILD; CYCLOOXYGENASE 2 INHIBITORS; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; FEMALE; HUMANS; MALE; PYRIDINES; RETROSPECTIVE STUDIES; SULFONES; THIAZINES; THIAZOLES; URTICARIA;

EID: 84896071537     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12674     Document Type: Article

References (16)

1. Zambonino MA, Torres MJ, Muñoz C, et al,. Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Immunol 2013; 24: 151-9.
2. Doña I, Blanca-Lõpez N, Cornejo-García JA, et al,. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011; 41: 86-95.
3. Szczeklik A, Nizankowska E, Sanak M,. Hypersensitivity to aspirin and non-steroidal antiinflammtory drugs. In: Middelton's Allergy, Principles and Practice (, Adkinson NF, Bochner BS, Busse WW, Holgate S, Lemanske RF, Simons FE, eds), 7th edn. Philadelphia: Mosby, 2009; 1227-43.
4. Kidon MI, Kang LW, Chin CW, et al,. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children. Pediatrics 2005; 116: 675-80.
5. Boussetta K, Ponvert C, Karila C, et al,. Hypersensitivity reactions to paracetamol in children: a study of 25 cases. Allergy 2005; 60: 1174-7. (Pubitemid 41153146)
6. Stevenson DD, Szczeklik A,. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006; 118: 773-86. (Pubitemid 44515109)
7. Doña I, Blanca-Lõpez N, Jagemann LR, et al,. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs. Allergy 2011; 66: 1428-33.
8. Göksel O, Aydin O, Misirligil Z, et al,. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema. J Dermatol 2010; 37: 973-9.
9. Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A,. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug induced urticaria and angioedema. Ann Allergy Asthma Immunol 2005; 95: 154-8. (Pubitemid 41170176)
10. Viola M, Quaratino D, Volpetti S, et al,. Parecoxib tolerability in patients with hypersensitivity to nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol 2006; 117: 1189-91.
11. Weberschock TB, Muller SM, Boehncke S, et al,. Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature. Arch Dermatol Res 2007; 299: 169-75. (Pubitemid 46955882)
12. Matucci A, Parronchi P, Vultaggio A, et al,. Partial safety of the new COX-2 inhibitor rofecoxib in NSAIDs high sensitive patients. Allergy 2004; 59: 1133-4. (Pubitemid 39279118)
13. Sánchez-Borges M,. A novel phenotype of nonsteroidal anti-inflammatory drug hypersensitivity. The high-risk patient. World Allergy Organ J 2009; 2: 17-19.
14. Malskat WS, Knulst AC, Bruijnzeel-Koomen CA, Röckmann H,. Tolerance to alternative cyclooxygenase-2 inhibitors in nonsteroidal anti-inflammatory drug hypersensitive patients. Clin Transl Allergy 2013; 3: 20-7.
15. Viola M, Rumi G, Valluzzi RL, et al,. Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity. Clin Exp Allergy 2011; 41: 96-103.
16. Blanca-Lõpez N, Torres MJ, Doña I, et al,. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance. Clin Exp Allergy 2013; 43: 85-91.